Home › Drugs by Condition › C › Conjunctivitis, Allergic › Levocabastine Pregnancy Warnings
Print Save or Share

Levocabastine ophthalmic Pregnancy and Breastfeeding Warnings

Levocabastine ophthalmic is also known as: Livostin

Levocabastine ophthalmic Pregnancy Warnings

Levocabastine has been assigned to pregnancy category C by the FDA. Animal studies at doses 16,500 to 66,000 times the maximum recommended human ocular dose have demonstrated teratogenicity. There are no controlled data in human pregnancy. Levocabastine should only be given during pregnancy when benefit outweighs risk.

Levocabastine ophthalmic Breastfeeding Warnings

Levocabastine is excreted into human milk. In one nursing woman, the daily dose in the infant after maternal ophthalmic instillation was approximately 0.5 mcg. Adverse effects in the infant are unlikely.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

(web5)